TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 16617400

Group type: EXPERIMENTAL
Intervention: Serum ICTP in patients with BC and bone metastases
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Serum CA 15‐3 in patients with BC and bone metastases
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Serum PICP in patients with BC and bone metastases
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Serum CEA in patients with BC and bone metastases
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Combination of CA 15‐3, ICTP, and CEA
Number of subjects: 97

Group type: COMPARATOR
Intervention: Bone scintigraphy
Number of subjects: 97
Study: 12672684

Group type: EXPERIMENTAL
Intervention: 2.00 US dollar bill
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: 5.00 US dollars check
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: 1.00 US dollar bill
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: 2.00 US dollars check
Number of subjects: 300

Group type: COMPARATOR
Intervention: no incentive
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: 1.00 US dollar bill (sent to remaining nonresponders)
Number of subjects: 300
Study: 10700536

Group type: EXPERIMENTAL
Intervention: Total parenteral nutrition (Group I, n=15)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Hypocaloric parenteral nutrition (Group II, n=7)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Total parenteral nutrition (Group I)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Hypocaloric parenteral nutrition (Group II)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 22
Study: 8851401

Group type: EXPERIMENTAL
Intervention: CTAP
Number of subjects: 26

Group type: COMPARATOR
Intervention: MR imaging
Number of subjects: 26
Study: 1391107

Group type: COMPARATOR
Intervention: Conventional fluid therapy (Control Group I)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Nutritional support based on glucose and aminoacid (Group II)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Nutritional therapy based on glycerol and aminoacid (Group III)
Number of subjects: 35
Study: 6437257

Group type: EXPERIMENTAL
Intervention: Cessation and maintenance manuals (C + M)
Number of subjects: 1237

Group type: COMPARATOR
Intervention: Leaflets (L)
Number of subjects: 1237

Group type: EXPERIMENTAL
Intervention: Leaflets plus maintenance manual (L + M)
Number of subjects: 1237

Group type: EXPERIMENTAL
Intervention: Cessation manual (C)
Number of subjects: 1237
Study: 31567637

Group type: EXPERIMENTAL
Intervention: Split-dose polyethylene glycol with electrolyte solution
Number of subjects: 45

Group type: COMPARATOR
Intervention: Full single-dose polyethylene glycol with electrolyte solution
Number of subjects: 45
Study: 29730649

Group type: EXPERIMENTAL
Intervention: DXplain intervention group (43 residents)
Number of subjects: 87

Group type: COMPARATOR
Intervention: Control group (44 residents)
Number of subjects: 87
Study: 28294745

Group type: EXPERIMENTAL
Intervention: Bisoprolol
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Ivabradine
Number of subjects: 126
Study: 24595632

Group type: EXPERIMENTAL
Intervention: Higher-complex carbohydrate (HCC)/lower-fat (LF) CHOICE diet (60% carbohydrate, 25% fat, 15% protein)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Higher-complex carbohydrate (HCC)/lower-fat (LF) CHOICE diet
Number of subjects: 16

Group type: COMPARATOR
Intervention: Conventional lower-carbohydrate/HF diet (40% carbohydrate, 45% fat, 15% protein)
Number of subjects: 16
Study: 22866767

Group type: EXPERIMENTAL
Intervention: Aggressive treatment (≥3 concomitantly used antihypertensive medications)
Number of subjects: 22576

Group type: COMPARATOR
Intervention: Conventional treatment (≤2 concomitantly used antihypertensive medications)
Number of subjects: 22576
Study: 20560814

Group type: EXPERIMENTAL
Intervention: i‐FOBT
Number of subjects: 20623

Group type: COMPARATOR
Intervention: g‐FOBT
Number of subjects: 20623
Study: 17388709

Group type: EXPERIMENTAL
Intervention: Rapid initiation of quetiapine (200 mg on day 1, 400 mg on day 2, 600 mg on day 3, 800 mg on day 4)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Conventional initiation of quetiapine (50 mg on day 1, 100 mg on day 2, increased in 100 mg/day increments to reach 400 mg on day 5)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 40
Study: 16216030

Group type: EXPERIMENTAL
Intervention: Quality Improvement (QI) program for CRC screening
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 32
Study: 12392586

Group type: EXPERIMENTAL
Intervention: Endothelin-1 (ET-1) infusion at 2.5 pmol min-1
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Endothelin-1 (ET-1) infusion at 10 pmol min-1
Number of subjects: 8
Study: 10543321

Group type: EXPERIMENTAL
Intervention: midazolam-bupivacaine mixture (group M; n = 15)
Number of subjects: 30

Group type: COMPARATOR
Intervention: bupivacaine alone (group B; n = 15)
Number of subjects: 30
Study: 7750527

Group type: EXPERIMENTAL
Intervention: Low-dose BCG (75 mg)
Number of subjects: 183

Group type: COMPARATOR
Intervention: Standard-dose BCG (150 mg)
Number of subjects: 183
Study: 2125243

Group type: COMPARATOR
Intervention: Placebo for eight weeks
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 40 mg of pravastatin daily for 24 weeks
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 80 mg of pravastatin daily for 24 weeks
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 24 gm of cholestyramine daily for 24 weeks
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 40 mg of pravastatin plus 24 gm of cholestyramine daily for 24 weeks
Number of subjects: 40
Study: 437308

Group type: EXPERIMENTAL
Intervention: Phyllocontin Continus tablets
Number of subjects: 24

Group type: COMPARATOR
Intervention: Alupent tablets
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Phyllocontin tablets alone
Number of subjects: 24

Group type: COMPARATOR
Intervention: Ventolin tablets alone
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Phyllocontin tablets with inhaled Ventolin
Number of subjects: 24

Group type: COMPARATOR
Intervention: Ventolin tablets with inhaled Ventolin
Number of subjects: 24
Study: 31915173

Group type: EXPERIMENTAL
Intervention: Individual Early Warning Score (I-EWS)
Number of subjects: 150000

Group type: COMPARATOR
Intervention: National Early Warning Score (NEWS)
Number of subjects: 150000
Study: 30393978

Group type: EXPERIMENTAL
Intervention: Fructose breath tests (open twice and blinded once)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Water (blind neutral nocebo)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Cyclamate/saccharine sweetener (blind sweet nocebo)
Number of subjects: 31
Study: 26233594

Group type: EXPERIMENTAL
Intervention: 3 IA doses of PRP
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: 1 dose of PRP
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: 1 dose of HA
Number of subjects: 162

Group type: COMPARATOR
Intervention: Saline injection (control)
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: 3 IA doses of PRP (early OA subgroup)
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: Any treatment group (advanced OA subgroup)
Number of subjects: 162
Study: 25920297

Group type: EXPERIMENTAL
Intervention: Combination of dexamethasone (8 mg) and metoclopramide (10 mg)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Metoclopramide (10 mg) with normal saline solution (1.6 ml)
Number of subjects: 100
Study: 24013497

Group type: EXPERIMENTAL
Intervention: Low-dose GH therapy (0.025 mg/kg/day)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: High-dose GH therapy (0.05 mg/kg/day)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: GH therapy (0.05 mg/kg/day for 12 months)
Number of subjects: 16
Study: 20671716

Group type: EXPERIMENTAL
Intervention: Synchronized Intermittent Mandatory Ventilation (SIMV)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: High-Frequency Oscillatory Ventilation (HFOV)
Number of subjects: 24
Study: 19826305

Group type: EXPERIMENTAL
Intervention: Intermittent stretching (2-3 days/week)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Standard stretching protocol (daily for 4 weeks, then discontinued)
Number of subjects: 32
Study: 16952097

Group type: EXPERIMENTAL
Intervention: PPV with ILM removal
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control (untreated fellow eyes)
Number of subjects: 10
Study: 11996943

Group type: EXPERIMENTAL
Intervention: Atorvastatin (10-40 mg)
Number of subjects: 103

Group type: COMPARATOR
Intervention: Bezafibrate (400 mg)
Number of subjects: 103
Study: 10505027

Group type: EXPERIMENTAL
Intervention: Combined modality treatment
Number of subjects: 194

Group type: EXPERIMENTAL
Intervention: Enrolled in clinical trials
Number of subjects: 194

Group type: COMPARATOR
Intervention: Treated outside of randomised studies
Number of subjects: 194

Group type: EXPERIMENTAL
Intervention: Combined modality regimens
Number of subjects: 194

Group type: COMPARATOR
Intervention: Radiation or chemotherapy alone
Number of subjects: 194

Group type: EXPERIMENTAL
Intervention: Patients enrolled in clinical trials
Number of subjects: 194

Group type: EXPERIMENTAL
Intervention: Overall group of 225 patients
Number of subjects: 194
Study: 7589657

Group type: EXPERIMENTAL
Intervention: Ovulation induction with gonadotropins associated with timed vaginal intercourse (group A)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Ovulation induction with gonadotropins associated with IUI (group B)
Number of subjects: 200
Study: 2371573

Group type: EXPERIMENTAL
Intervention: Diane contraceptive pill
Number of subjects: 59

Group type: COMPARATOR
Intervention: Microgynon 50 contraceptive pill
Number of subjects: 59
Study: 549212

Group type: EXPERIMENTAL
Intervention: S-adenosyl-L-methionine (SAMe)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Amitriptyline
Number of subjects: 0
Study: 30626197

Group type: EXPERIMENTAL
Intervention: Sauti ya Vijana (The Voice of Youth) intervention, consisting of ten group sessions and two individual sessions led by trained group leaders.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Treatment as usual (control group)
Number of subjects: 0
Study: 27022625

Group type: EXPERIMENTAL
Intervention: Naloxone administration in healthy individuals
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Naloxone administration in chronic pain patients
Number of subjects: 0

Group type: COMPARATOR
Intervention: Baseline condition in chronic pain patients
Number of subjects: 0
Study: 26353815

Group type: EXPERIMENTAL
Intervention: Low-cost simulation model
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High-cost simulation model
Number of subjects: 0

Group type: COMPARATOR
Intervention: No simulation training
Number of subjects: 0
Study: 23965480

Group type: EXPERIMENTAL
Intervention: True acupuncture
Number of subjects: 214

Group type: COMPARATOR
Intervention: Nonpenetrating acupuncture
Number of subjects: 214
Study: 21505219

Group type: EXPERIMENTAL
Intervention: Calcium and Vitamin D (1g calcium and 400 IU vitamin D daily)
Number of subjects: 36282

Group type: COMPARATOR
Intervention: Calcium and Vitamin D
Number of subjects: 36282

Group type: COMPARATOR
Intervention: Calcium or Calcium and Vitamin D
Number of subjects: 36282
Study: 19011439

Group type: EXPERIMENTAL
Intervention: Olanzapine 15 mg
Number of subjects: 313

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 313
Study: 16625452

Group type: EXPERIMENTAL
Intervention: Mediocarpal arthrodesis (MA)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Total wrist arthrodesis (TA)
Number of subjects: 22
Study: 13680082

Group type: EXPERIMENTAL
Intervention: 25 mg doxepin (single i.v.)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 25 mg doxepin (subchronic p.o.)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo (single i.v.)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Both doxepin administrations
Number of subjects: 10
Study: 10584984

Group type: EXPERIMENTAL
Intervention: Prednisone 10 mg/day starting 1 month before ovulation induction for patients positive for ovarian autoantibodies (ov-ab).
Number of subjects: 80

Group type: COMPARATOR
Intervention: Seronegative study group (no treatment).
Number of subjects: 80
Study: 7787537

Group type: EXPERIMENTAL
Intervention: Oral co-amoxiclav
Number of subjects: 541

Group type: COMPARATOR
Intervention: Intravenous followed by oral co-amoxiclav
Number of subjects: 541

Group type: COMPARATOR
Intervention: Intravenous followed by oral cephalosporins
Number of subjects: 541

Group type: EXPERIMENTAL
Intervention: Oral antibiotics
Number of subjects: 541

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 541
Study: 2081065

Group type: EXPERIMENTAL
Intervention: Cognitive-behaviour therapy plus diazepam
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Cognitive-behaviour therapy alone
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Cognitive-behaviour therapy plus placebo
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Diazepam alone
Number of subjects: 101

Group type: COMPARATOR
Intervention: Placebo alone
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Cognitive-behaviour therapy (either alone or in combination)
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: All treatment groups
Number of subjects: 101
Study: 485782

Group type: EXPERIMENTAL
Intervention: Pretraining using a cognitive-experiential approach
Number of subjects: 5

Group type: COMPARATOR
Intervention: Nonpretrained groups
Number of subjects: 5
Study: 30937618

Group type: EXPERIMENTAL
Intervention: Full laparoscopic technique for minor resections
Number of subjects: 214

Group type: EXPERIMENTAL
Intervention: Hand-assisted technique for minor resections
Number of subjects: 214

Group type: EXPERIMENTAL
Intervention: Full laparoscopic technique for major resections
Number of subjects: 214

Group type: EXPERIMENTAL
Intervention: Robotic technique for minor resections
Number of subjects: 214

Group type: COMPARATOR
Intervention: Robotic technique for major resections
Number of subjects: 214

Group type: COMPARATOR
Intervention: Hand-assisted technique for major resections
Number of subjects: 214
Study: 30063297

Group type: EXPERIMENTAL
Intervention: Albiglutide 50 mg liquid formulation from an auto-injector (Regimen A)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Lyophilized placebo from a DCC pen-injector (Regimen A)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Placebo liquid from an auto-injector (Regimen B)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Lyophilized albiglutide 50 mg from a DCC pen-injector (Regimen B)
Number of subjects: 59
Study: 29284520

Group type: EXPERIMENTAL
Intervention: TangBi Formula plus mecobalamin
Number of subjects: 188

Group type: COMPARATOR
Intervention: Placebo plus mecobalamin
Number of subjects: 188
Study: 26725253

Group type: EXPERIMENTAL
Intervention: Definitely echolucent plaques (> 25% soft plaque)
Number of subjects: 814

Group type: COMPARATOR
Intervention: Definitely nonecholucent plaques (< 25% soft plaque)
Number of subjects: 814

Group type: EXPERIMENTAL
Intervention: Plaque echolucency
Number of subjects: 814
Study: 25379844

Group type: EXPERIMENTAL
Intervention: Circular plastic wound edge protectors (CWEPs)
Number of subjects: 608

Group type: COMPARATOR
Intervention: Standard surgical towels (control)
Number of subjects: 608
Study: 23248412

Group type: EXPERIMENTAL
Intervention: Papaya dressing
Number of subjects: 64

Group type: COMPARATOR
Intervention: Hydrogen peroxide dressing
Number of subjects: 64
Study: 19254119

Group type: EXPERIMENTAL
Intervention: Metronidazole 500 mg and Amoxicillin 375 mg, three times a day for 7 days
Number of subjects: 51

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 51
Study: 17223217

Group type: EXPERIMENTAL
Intervention: vildagliptin 50 mg qd
Number of subjects: 354

Group type: EXPERIMENTAL
Intervention: vildagliptin 50 mg bid
Number of subjects: 354

Group type: EXPERIMENTAL
Intervention: vildagliptin 100 mg qd
Number of subjects: 354

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 354
Study: 15840675

Group type: EXPERIMENTAL
Intervention: Cinacalcet
Number of subjects: 14
Study: 12678168

Group type: EXPERIMENTAL
Intervention: Zuclopenthixol acetate (ZPTA) 50-100 mg
Number of subjects: 70

Group type: COMPARATOR
Intervention: Haloperidol (HAL) 5-10 mg
Number of subjects: 70
Study: 9619545

Group type: EXPERIMENTAL
Intervention: Fine needle aspiration (FNA)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Open excisional biopsy
Number of subjects: 102
Study: 7622272

Group type: EXPERIMENTAL
Intervention: Cefaclor 250 mg at bedtime for 12 months
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Macrocrystalline nitrofurantoin 50 mg at bedtime for 12 months
Number of subjects: 120
Study: 29233615

Group type: EXPERIMENTAL
Intervention: Higher overall HEI‐2010 score (healthier diet)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Higher HEI‐2010 score in women with prior chemotherapy
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: HEI‐2010 score
Number of subjects: 44
Study: 27595722

Group type: EXPERIMENTAL
Intervention: Biodentine
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Mineral Trioxide Aggregate (MTA)
Number of subjects: 90
Study: 26441146

Group type: EXPERIMENTAL
Intervention: Heroin administration
Number of subjects: 49

Group type: COMPARATOR
Intervention: Placebo administration
Number of subjects: 49
Study: 23104147

Group type: EXPERIMENTAL
Intervention: Continuous femoral nerve block alone (group F)
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Single-injection sciatic nerve block combined with continuous femoral nerve block (group Fs)
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Continuous sciatic nerve block combined with continuous femoral nerve block (group FCS)
Number of subjects: 89
Study: 21357381

Group type: EXPERIMENTAL
Intervention: Genotype-environment interactions tested using genome-wide data
Number of subjects: 1191

Group type: EXPERIMENTAL
Intervention: Previously reported susceptibility loci
Number of subjects: 1191
Study: 19791831

Group type: EXPERIMENTAL
Intervention: Lidocaine 5% medicated plaster
Number of subjects: 0
Study: 16890834

Group type: EXPERIMENTAL
Intervention: fosamprenavir-ritonavir 700 mg/100 mg twice daily
Number of subjects: 878

Group type: COMPARATOR
Intervention: lopinavir-ritonavir 400 mg/100 mg twice daily
Number of subjects: 878

Group type: EXPERIMENTAL
Intervention: fosamprenavir-ritonavir
Number of subjects: 878

Group type: COMPARATOR
Intervention: lopinavir-ritonavir
Number of subjects: 878
Study: 15253741

Group type: EXPERIMENTAL
Intervention: Intravenous iron administration (40 mg of saccharated ferric oxide after every dialysis session for four weeks)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control group (vehicle treatment)
Number of subjects: 22
Study: 11509476

Group type: EXPERIMENTAL
Intervention: Sodium depletion (acute)
Number of subjects: 158

Group type: EXPERIMENTAL
Intervention: Sodium depletion (chronic)
Number of subjects: 158

Group type: COMPARATOR
Intervention: Saline infusion (2-hour)
Number of subjects: 158

Group type: COMPARATOR
Intervention: Controlled sodium intake
Number of subjects: 158

Group type: COMPARATOR
Intervention: Salt-sensitive group (baseline)
Number of subjects: 158

Group type: COMPARATOR
Intervention: Salt-resistant group (baseline)
Number of subjects: 158

Group type: COMPARATOR
Intervention: Chronic salt-sensitive group (baseline)
Number of subjects: 158

Group type: COMPARATOR
Intervention: Chronic salt-resistant group (baseline)
Number of subjects: 158
Study: 9240990

Group type: EXPERIMENTAL
Intervention: Piroxicam
Number of subjects: 364

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 364
Study: 8237822

Group type: EXPERIMENTAL
Intervention: Implantable cardioverter‐defibrillator (ICD) therapy
Number of subjects: 400

Group type: COMPARATOR
Intervention: Amiodarone
Number of subjects: 400
Study: 3443058

Group type: EXPERIMENTAL
Intervention: Plain felodipine tablets, 10mg bid for 10 days
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Extended release felodipine, 20mg once every morning
Number of subjects: 2

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2
Study: 29802967

Group type: EXPERIMENTAL
Intervention: Manhood 2.0 program
Number of subjects: 866

Group type: COMPARATOR
Intervention: Job readiness training program
Number of subjects: 866
Study: 27923862

Group type: EXPERIMENTAL
Intervention: Motivational interviewing-informed strategy during group orientations
Number of subjects: 90
Study: 24955731

Group type: EXPERIMENTAL
Intervention: DHA diet supplementation (1.14 g per day for eight weeks)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Training season and acute exercise
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control (placebo) group
Number of subjects: 15
Study: 22249017

Group type: EXPERIMENTAL
Intervention: Dix-Hallpike manoeuvre performed in the morning and afternoon sequence.
Number of subjects: 50
Study: 20849609

Group type: EXPERIMENTAL
Intervention: Obese women (BMI 30-34.9 kg/m2)
Number of subjects: 1661

Group type: EXPERIMENTAL
Intervention: Overweight women (BMI 25-29.9 kg/m2)
Number of subjects: 1661

Group type: EXPERIMENTAL
Intervention: Babies of obese women (BMI 30-34.9 kg/m2)
Number of subjects: 1661
Study: 18201893

Group type: EXPERIMENTAL
Intervention: Bupivacaine 0.5% (15 ml bolus, 10 ml every 6h)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Ropivacaine 0.2% (20 ml bolus, 15 ml every 6h)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Anterior Thoracotomy with Bupivacaine
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Anterior Thoracotomy with Ropivacaine
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Posterolateral Thoracotomy with Bupivacaine
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Posterolateral Thoracotomy with Ropivacaine
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Overall (both groups)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Anterior Thoracotomy vs Posterolateral Thoracotomy
Number of subjects: 70

Group type: COMPARATOR
Intervention: Bupivacaine vs Ropivacaine
Number of subjects: 70
Study: 16355302

Group type: COMPARATOR
Intervention: Transcranial and paravertebral magnetic stimulation
Number of subjects: 68

Group type: COMPARATOR
Intervention: Transcranial stimulation
Number of subjects: 68
Study: 12570114

Group type: EXPERIMENTAL
Intervention: salbutamol
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: formoterol
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: salmeterol
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: oxitropium
Number of subjects: 20

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 20
Study: 10349064

Group type: EXPERIMENTAL
Intervention: Carvedilol
Number of subjects: 1094
Study: 7852252

Group type: EXPERIMENTAL
Intervention: Fluoxetine 40 mg/day
Number of subjects: 18

Group type: COMPARATOR
Intervention: Fluoxetine 20 mg/day
Number of subjects: 18